DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sarrazin C, Dvory-Sobol H, Svarovskaia ES. , et al.
The prevalence and the effect of HCV NS5A resistance associated variants in subjects with compensated cirrhosis treated with ledipasvir/sofosbuvir +/− RBV.
J Hepatol 2015;
62 (Suppl. 02) S620
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.